Patent details

Basic Information

Publication number:

92327

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP068459395

Legal Status:

Inactive

Application number:

92327

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/13/001-004 ICLUSIG - ponatinib

Marketing Authorization Type:

Marketing Authorization Date:

03/07/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

05/12/2013

First Marketing Authorization date:

03/07/2013

Grant date:

05/02/2014

Activation date:

Publication date:

05/02/2014

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

03/07/2028

SPC Extension Expiration:

03/07/2028

Rejection date:

Withdrawal date:

Owner

From:

14/02/2025

 

 

Name:

TAKEDA PHARMACEUTICALS U.S.A., INC.

Address:

500 Kendall Street, MA 02142 /USA, Cambridge, , United States (US)

History of Owners

From:

05/12/2013

To:

14/02/2025

Name:

ARIAD PHARMACEUTICALS INC.

Address:

26 Landsdowne Street, Cambridge, MA 02139-4234, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

05/12/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

THOMAS R., Mathew

Address:

United States (US)

2

Name:

ZOU Dong

Address:

United States (US)

3

Name:

SUNDARAMOORTHI Rajeswari

Address:

United States (US)

4

Name:

ZHU Xiaotian

Address:

United States (US)

5

Name:

ROMERO Jan Antoinette, C.

Address:

United States (US)

6

Name:

SAWYER Tomi, K.

Address:

United States (US)

7

Name:

METCALF Chester, A., III

Address:

United States (US)

8

Name:

SHAKESPEARE William, C.

Address:

United States (US)

9

Name:

QI Jiwei

Address:

United States (US)

10

Name:

HUANG Wei-sheng

Address:

United States (US)

11

Name:

DALGARNO David, C.

Address:

United States (US)

12

Name:

WANG Yihan

Address:

United States (US)

Publication

Bulletin

1

Bulletin Heading:

SPC4

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:

CO

Bulletin edition number:

2025/04

Publication date:

04/03/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20250000055A

Date Registered:

14/02/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

TAKEDA PHARMACEUTICALS U.S.A., INC.

Address:

500 Kendall Street, MA 02142 /USA, Cambridge, , United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/12/2026

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
16/01/2019	Publication	1
16/01/2019	Outgoing Correspondence	1
24/10/2016	Incoming Correspondence (Post)	2
14/02/2025	Request For Change	4
14/02/2025	Outgoing Correspondence	1